UnknownPhase 1/2

Observation of Cough Variant Asthma Treated in Combination of Chanqin Granules.

China120 participantsStarted 2017-11-01

Plain-language summary

This single-center, randomized, double-blind, placebo-controlled trial was undertaken at an outpatient clinic in Shuguang Hospital. Newly diagnosed cough variant asthma adult patients with the T.C.M. pattern of pathogenic-wind are randomly divided into treatment and control group, with 60 patients in each group. Clinical observation of the Respiratory Impedance and Inflammation in Cough Variant Asthma adults reated in Combination of Chanqin Granules.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Diagnosis of cough variant asthma according to Western medicine
✓. Diagnosis of cough with pathogenic wind syndrome according to TCM
✓. Aged between 18 to 70 years, regardless of gender, race or educational and economic status
✓. The cough symptom should last for at least 8 weeks

Exclusion criteria

✕. Patients with history of smoking (or quite smoking for less than 6 months)
✕. Systemic use of corticosteroids in the past 4 weeks
✕. Upper or lower respiratory tract infection in the past 4 weeks
✕. Incapable of corporation with spirometry and FeNO test
✕. Other chronic respiratory disease eg: COPD, pulmonary cirrhosis
✕. Women who are pregnant or preparing to become pregnant or breast feeding women

What they're measuring

Impulse Oscillometry

Timeframe: 2 week

Trial details

NCT IDNCT03319043

SponsorShanghai University of Traditional Chinese Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-12-30

Contact for this trial

XUAN CHEN, Master

+86-13611899735 chen77xuan@aliyun.com

View on ClinicalTrials.gov More Cough Variant Asthma trials